{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:37:27Z","timestamp":1753875447168,"version":"3.41.2"},"reference-count":4,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"#160;"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2129931","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T14:50:00Z","timestamp":1666795800000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Inactivated COVID-19 vaccines, HBV and HIV: Correspondence"],"prefix":"10.1080","volume":"18","author":[{"given":"Pathum","family":"Sookaromdee","sequence":"first","affiliation":[{"name":"Private Academic Consultant, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viroj","family":"Wiwanitkit","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr DY Patil University, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2110799"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003318"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994173"},{"issue":"1","key":"e_1_3_3_5_1","first-page":"1","article-title":"Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background","volume":"14","author":"Yasri S","year":"2022","unstructured":"Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol. 2022 Feb 15;14(1):1\u20133.","journal-title":"Int J Physiol Pathophysiol Pharmacol"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2129931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:46:31Z","timestamp":1737049591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2129931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2129931"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2129931","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2129931"}}